ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Single-Nucleus RNA Sequencing Reveals Mid-Gestational Neurodevelopment Features in the Superior Temporal Plane from Fetuses with Nonsyndromic Cleft Lip and Palate.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Nucleus RNA Sequencing Reveals Mid-Gestational Neurodevelopment Features in the Superior Temporal Plane from Fetuses with Nonsyndromic Cleft Lip and Palate.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Nonsyndromic cleft lip and palate (NSCLP) is a common craniofacial malformation increasingly recognized to involve neurodevelopmental abnormalities, though the molecular basis remains unclear. Here, single-nucleus RNA sequencing of the superior temporal plane from mid-gestation NSCLP fetuses is performed, and profound alterations in cell-type composition, intercellular communication, and transcriptional programs are uncovered. Integrative analyses with weighted gene co-expression network analysis and single-cell regulatory network interference and clustering based on single-nucleus transcriptomes identify myocyte enhancer factor 2C (MEF2C) as a shared transcriptional regulator consistently downregulated in excitatory and inhibitory neurons across mid-term gestation, which is validated in NSCLP fetal brain tissues. MEF2C expression is negatively correlated with synaptophysin immunofluorescence intensity. In MEF2C-deficient primary cortical neurons, impaired synaptic formation, reduced postsynaptic density protein-95 expression, and weakened excitatory postsynaptic transmission without altering intrinsic excitability are found. Upstream regulators of MEF2C are enriched for pathways controlling neuronal differentiation, synaptic plasticity, and epigenetic regulation, suggesting broad disruption of neurodevelopmental programs. Together, this study provides molecular evidence of disrupted brain development in NSCLP and implicates MEF2C as a potential mediator of neurodevelopmental impairments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.